Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald F Watts

Showing results (561-570 of 706) with videos related to

Pageof 71
Sort By:
Geroscience|August 23, 2023
Sex-dependent associations of plasma high-density lipoprotein cholesterol and mortality risk in healthy older men and women: two prospective cohort studiesSultana Monira Hussain, Andrew M Tonkin, Gerald F Watts, et al.
Scientific Reports|January 11, 2020
Bile acid bio-nanoencapsulation improved drug targeted-delivery and pharmacological effects via cellular flux: 6-months diabetes preclinical studyArmin Mooranian, Susbin Raj Wagle, Bozica Kovacevic, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 27, 2021
Pharmacodynamic effect of bempedoic acid and statin combinations: predictions from a dose-response modelSatyawan B Jadhav, Ryan L Crass, Sunny Chapel, et al.
The New England Journal of Medicine|September 3, 2024
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis RiskGerald F Watts, Robert S Rosenson, Robert A Hegele, et al.
Circulation|November 16, 2024
Temporal Effects of Plozasiran on Lipids and Lipoproteins in Persistent ChylomicronemiaGerald F Watts, Robert A Hegele, Robert S Rosenson, et al.
Journal of Paediatrics and Child Health|July 15, 2022
Integrated guidance to enhance the care of children and adolescents with familial hypercholesterolaemia: Practical advice for the community clinicianAri E Horton, Andrew C Martin, Shubha Srinivasan, et al.
Atherosclerosis|July 30, 2015
Lipoprotein (a) levels are not associated with carotid plaques and carotid intima media thickness in statin-treated patients with familial hypercholesterolemiaSven Bos, Martijne H C Duvekot, Adriana C Touw-Blommesteijn, et al.
American Journal of Preventive Cardiology|April 17, 2025
Recognition and management of persistent chylomicronemia: A joint expert clinical consensus by the National Lipid Association and the American Society for Preventive CardiologySeyedmohammad Saadatagah, Miriam Larouche, Mohammadreza Naderian, et al.
Atherosclerosis|April 23, 2026
Risk factors for atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolemia: a systematic review and meta-analysisMaría Elena Mansilla-Rodríguez, José Luis Sánchez-Ramos, Alina Rigabert Sánchez-Junco, et al.
Heart, Lung & Circulation|May 29, 2012
A new model of care for familial hypercholesterolaemia: what is the role of cardiology?Gerald F Watts, David R Sullivan, Frank M van Bockxmeer, et al.
Pageof 71

Showing results (561-570 of 706) with videos related to

Sort By:
Pageof 71
Geroscience|August 23, 2023
Sex-dependent associations of plasma high-density lipoprotein cholesterol and mortality risk in healthy older men and women: two prospective cohort studiesSultana Monira Hussain, Andrew M Tonkin, Gerald F Watts, et al.
Scientific Reports|January 11, 2020
Bile acid bio-nanoencapsulation improved drug targeted-delivery and pharmacological effects via cellular flux: 6-months diabetes preclinical studyArmin Mooranian, Susbin Raj Wagle, Bozica Kovacevic, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 27, 2021
Pharmacodynamic effect of bempedoic acid and statin combinations: predictions from a dose-response modelSatyawan B Jadhav, Ryan L Crass, Sunny Chapel, et al.
The New England Journal of Medicine|September 3, 2024
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis RiskGerald F Watts, Robert S Rosenson, Robert A Hegele, et al.
Circulation|November 16, 2024
Temporal Effects of Plozasiran on Lipids and Lipoproteins in Persistent ChylomicronemiaGerald F Watts, Robert A Hegele, Robert S Rosenson, et al.
Journal of Paediatrics and Child Health|July 15, 2022
Integrated guidance to enhance the care of children and adolescents with familial hypercholesterolaemia: Practical advice for the community clinicianAri E Horton, Andrew C Martin, Shubha Srinivasan, et al.
Atherosclerosis|July 30, 2015
Lipoprotein (a) levels are not associated with carotid plaques and carotid intima media thickness in statin-treated patients with familial hypercholesterolemiaSven Bos, Martijne H C Duvekot, Adriana C Touw-Blommesteijn, et al.
American Journal of Preventive Cardiology|April 17, 2025
Recognition and management of persistent chylomicronemia: A joint expert clinical consensus by the National Lipid Association and the American Society for Preventive CardiologySeyedmohammad Saadatagah, Miriam Larouche, Mohammadreza Naderian, et al.
Atherosclerosis|April 23, 2026
Risk factors for atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolemia: a systematic review and meta-analysisMaría Elena Mansilla-Rodríguez, José Luis Sánchez-Ramos, Alina Rigabert Sánchez-Junco, et al.
Heart, Lung & Circulation|May 29, 2012
A new model of care for familial hypercholesterolaemia: what is the role of cardiology?Gerald F Watts, David R Sullivan, Frank M van Bockxmeer, et al.
Pageof 71